Back to Charles Schwab Investment Management Inc. Charles Schwab Investment Management Inc.

VIRVIR

Showing 8 of 27 quarters

Position history for Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc.'s holdings in Vir Biotechnology, Inc.

Yes. Charles Schwab Investment Management holds 1,323,185 shares of VIR (Vir Biotechnology), worth $13.5M, as of its Q2 2026 13F filing. It increased the position by 151,501 shares (+12.9%) from Q1 2026. Charles Schwab Investment Management has held VIR in every 13F on record since Q4 2019, 27 quarterly filings.

Current Value

$13.5M

Current Shares

1.3M

Total Value Change

+$5M

Total Shares Change

+188,909

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+12.9%
$13.5M0.0%$10.19
32
2026-Q1
Increased
1.2M
+29.5%
$10.5M0.0%$8.91
35
2025-Q4
Decreased
904,480
-20.9%
$5.5M0.0%$5.84
0
2025-Q3
Decreased
1.1M
-11.6%
$6.5M0.0%$5.63
0
2025-Q2
Decreased
1.3M
-6.0%
$6.5M0.0%$5.17
0
2025-Q1
Increased
1.4M
+9.8%
$8.9M0.0%$6.70
30
2024-Q4
Increased
1.3M
+10.4%
$9.2M0.0%$7.33
31
2024-Q3
Increased
1.1M
+13.6%
$8.5M0.0%$7.53
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used